Although we can offer shares at any price we want, anyone
Although we can offer shares at any price we want, anyone with serious money will know they're getting hosed if we don't get some serious catalysts in the future, or do some financial engineering such that we don't get as great a deal (not that that's bad).
Example: We organically rise in price post successful tender exchange in anticipation of this plan. Let' say that get's us to 20 cents. Good, not crazy. We do a 1/10 split so new investors don't feel hosed. We successfully raise $20M for 10million new shares. The new company has $20M in capital, 25M shares O/S, 3/5 of which is us current shareholders, a 50M share A/S for future raises and to deal with the "controlled leak out" to pay back the legacies. This allows us to pursue success in trials and attract better financing. That's a good future on a national exchange, really all we can hope for, a stable chance at getting rewarded for changing the world of medicine.
Remember, in tandem with this pursuit, and a feeling of hope, more good things are going to continue to happen with MANF etc. Again, by the July uplist timeframe, successful CDNF data could be hot off the presses and people could be foaming at the mouth for AMBS. That will allow us to sell shares at a greater value ratio to current share holders and limit dilution while increasing runway.
3
Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Unseen Election Loser: Middle-Class Unity Seems like every four years, Americans shuffle the seats of power, but Paul Eckert believes the real problem isn't chairs changing; it's the folks sitting in them. With his book, "Healing Middle-Class Democracy," Eckert tackles a split as old as time—or at least since the '80s: the fracture within the middle class....
Continue Reading
Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...
Continue Reading
A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...
Continue Reading
Rolling Toward an Autonomous Future Alright, gearheads and tech buffs alike, gather 'round for a ride into the future of road travel. AutoMobility LA, a brainchild of the Los Angeles Auto Show, is revving up to give us a sneak peek into the era where cars don't just roll—they think. "The future's not about who's behind the wheel, but who's crafting the brain of the...
Continue Reading
The Legal Stakes: LINC's Critical Moment There's a storm at the gates for Lincoln Educational Services (NASDAQ: LINC), and it’s not just another day on Wall Street. We're looking at a securities class action that brings investors into the legal spotlight faster than you can say "diversify." November 10, 2026, marks the deadline for investors to jump into the fray and...
Continue Reading
Agentic Abilities: The Future of Embedded Development? If you think embedded development couldn't get snappier, Texas Instruments (TI) might just make you rethink that. They're ramping up their CCStudio ecosystem with some solid AI muscle, transforming the way engineers tackle embedded software tasks. This isn't your typical AI chatter—it's about chopping down...
Continue Reading
Peeling Back the Scrubs: Hidden Heroes in Vet Medicine Everyone's all-hands-on-deck when it's your furball on the line, but how much do you really know about what happens in those vet offices? Finally, National Veterinary Associates (NVA) is unzipping that mystery with a no-bones-about-it docuseries, Advancing Veterinary Medicine: Our Stories, right out of Austin, Texas....
Continue Reading
Gearing Up for Space Medicine: Enter Energenesis With the cosmic frontier drawing investor eyes and day-to-day operations inching skyward, here comes Energenesis Biomedical (TWSE: 6657), poking its head into space medicine. This isn’t just another biotech firm looking to throw drugs at terrestrial problems. No, Energenesis shot its shot at TASTI 2026 with its...
Continue Reading
FSBO.com Bets Big on Mobile With New App Launch FSBO.com has unleashed something that might just shake up how we think about buying and selling homes. They're not just rolling out apps—they're weaving another layer onto the fabric of real estate itself. While other players tossed their hats into the app game long ago, FSBO.com is kicking it up a notch with their new iOS...
Continue Reading
A Bright Future for Smart Meter Technology Revealed Some days look drearier than others in the tech game, but not this one. Fibocom and GridCrest just showcased their latest collaboration at Enlit Europe 2026 in Vienna, and it paints a pretty sparkling future for smart electricity meters. We're talking about the ME260 single-phase smart meter that promises to be a...
Continue Reading
Top 5 Most Recently Viewed Articles
Madam Paleta Tequila Receives Coveted Awards Madam Paleta Tequila has made a significant impact in the spirits industry, garnering attention for its unique flavors and dedication to quality. Recently, this female-founded tequila brand celebrated remarkable achievements at two esteemed competitions. Their Tamarind flavor was awarded Double Gold at the New York World...
Continue Reading
Can Investing in Stocks Make You a Millionaire? Definitely! Achieving millionaire status through stock investments is possible, but it requires following some important principles. First and foremost, diversifying your investments across a broad array of solid companies is key. It’s also vital to focus on the long term. By holding onto quality stocks for ten years or...
Continue Reading
Significant Increase in Distributions by Bancroft Fund Ltd. Bancroft Fund Ltd. (NYSE: BCV) has declared a noteworthy rise in its quarterly distribution, now raised to $0.35 per share from the previous $0.32. This move marks a 10% increase and will commence with the distribution planned for December, signifying a positive outlook for the fund and its investors. Financial...
Continue Reading
Robin Energy Ltd. Takes Bold Steps in Cryptocurrency Investment Robin Energy Ltd. (NASDAQ: RBNE), a prominent player in the international energy transportation sector, has recently announced a significant move towards cryptocurrency investment. The company has officially partnered with Anchorage Digital Bank, a pioneering institution in the digital asset banking space, to...
Continue Reading
Key Earnings Announcement for Performant Financial Corporation Performant Financial Corporation (Nasdaq: PFMT) is gearing up for its third quarter 2024 earnings report, set to be announced after the market closes on a designated day in the near future. This much-anticipated report will provide crucial insights into the company's ongoing performance, particularly in the...
Continue Reading